Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Waters Corporation and UCLA to Convene Leading Life Scientists

Published: Monday, September 06, 2010
Last Updated: Monday, September 06, 2010
Bookmark and Share
Will present latest research at applications of time of flight mass spectrometry conference September 13-15.

Waters Corporation and the University of California at Los Angeles (UCLA) will bring together some of the world’s leading life science researchers and practitioners of mass spectrometry (MS) at a conference this month to discuss the ways they are applying time-of-flight mass spectrometry to complex biomolecule research and analysis.

Waters announced the agenda and presentation topics for the Applications of Time of Flight Mass Spectrometry Conference, which will held at The Queen Mary in Long Beach, California, from September 13-15.

“This meeting provides an excellent platform for review and discussion of the most current theories and applications in time-of-flight mass spectrometry,” said Brian Smith, V.P. Mass Spectrometry Operations, Waters Division.  “The conference will bring together leaders with specialties in areas such as proteomics, chemistry and pharmacology, all of whom are gathering to share ideas and advance research.”

Meeting attendees and presenters hail from some of the most prestigious academic and industrial laboratories. Twenty-five presentations will be given on topics such as quantitative proteomics, drug discovery, probing protein conformation, protein complexes, metabolites, lipids and glycoproteins. The agenda for the conference and other details are available at

Waters scientists are presenting at the Applications of Time of Flight Mass Spectrometry Conference.  Copies of their presentations will be available for downloading from the Waters website shortly after the meeting concludes:

• Practical and Theoretical Constraints upon System-wide Protein Quantification by LC-MS , James Langridge
• Characterization of Protein Therapeutics by Ion-mobility Time-of-flight Mass Spectrometry, Weibin Chen
• Use of OA Login and OA Toolkit for Walkup Open Access Accurate Mass LC/MS, John Van Antwerp
• Development of a Lipidomic Platform Based on a Hybrid Quadrupole Time-Of-Flight (QTof) Ion-Mobility Mass Spectrometer for Both Targeted And Non-targeted Analysis, John Shockcor

Waters benchtop and research-grade time-of-flight (Tof) and quadrupole time-of-flight mass spectrometers (QTof) – the Waters Xevo®, Synapt® HDMS mass spectrometers, and LCT Premier™ –instruments known for their ability to elucidate the structure of biomolecules – be they individual proteins, protein complexes, protein metabolites, protein biomarkers.  Their ability to make exact mass measurements – pinpointing a molecular ion’s mass-to-charge ratio to four decimal places – makes Tof mass spectrometers a favorite for identifying unknown molecules and assigning them a structure.

Recent advances in technology are making Tof mass spectrometers more capable of quantifying proteins in samples enabling scientists to perform qualitative and quantitative experiments in a single analysis, something that was virtually impossible to do a few years ago.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Waters Centers of Innovation Program Honors CSU Laboratory
Proteomics and metabolomics facility recognized for innovation in biological mass spectrometry.
Wednesday, October 29, 2014
Waters Q3 Revenues up 8 Percent
Company reports third quarter sales of $493 million, an increase of 8% versus sales of $457 million in the third quarter of 2013.
Tuesday, October 21, 2014
Waters Report 8% Revenue Increase
Fourth quarter 2013 sales were $565 million, an increase of 8% compared to sales of $522 million in the fourth quarter of 2012.
Tuesday, January 28, 2014
Waters Acquires Nonlinear Dynamics
Nonlinear Dynamics is best known for their Progenesis software which offers researchers unique ways to analyze and visualize the raw proteomic data.
Thursday, August 08, 2013
New Phenome Centre will Decipher Roles of Nature and Nurture in Human Health
The MRC-NIHR Phenome Centre will examine around one hundred thousand blood and urine samples every year, putting the UK at the forefront of a revolution in health and medical research.
Wednesday, June 05, 2013
Waters Users’ Meeting at ASMS 2013
Register for the Waters Users’ meeting at ASMS 2013 and learn about the latest developments in Mass Spectrometry from Waters experts as we reveal our new technologies and solutions.
Monday, May 13, 2013
Waters Updates Alliance HPLC Designs without Impacting Established Validated Methods
The updated system will maintain key Alliance performance specifications and control algorithms to ensure that analysts can seamlessly replicate their existing methods.
Tuesday, February 26, 2013
Waters Corporation Releases 2012 Sustainability Report with GRI Certification
The report provides an in-depth review of the company’s sustainability efforts within the 2011 calendar year.
Thursday, October 25, 2012
Waters Selects Metabolomics Laboratory at University of North Texas for Center of Innovation Program Honors
New laboratory lirected by Prof. Vladimir Shulaev recognized for metabolomics and metabolic signaling pathway research and teaching.
Wednesday, September 26, 2012
Waters and Nonlinear Dynamics to Co-Develop Next Generation Research Solutions
Firms to combine complimentary expertise in analytical science and informatics to advance proteomics and metabolomics research.
Friday, August 03, 2012
Thomson Mass Spectrometry Laboratory Selected as Waters Center of Innovation
Waters recognizes Prof. Marcos Eberlin for pioneering mass spectrometry.
Tuesday, January 31, 2012
Waters Corporation and PREMIER Biosoft International Announce Collaboration for Advancing Lipidomics Research
Firms collaborate to redefine state of the art of lipidomics research by offering Ion mobility based lipid analysis solutions.
Tuesday, June 07, 2011
Scientific News
Gut Microbes Signal to the Brain When They're Full
Don't have room for dessert? The bacteria in your gut may be telling you something.
Turning up the Tap on Microbes Leads to Better Protein Patenting
Mining millions of proteins could become faster and easier with a new technique that may also transform the enzyme-catalyst industry, according to University of California, Davis, researchers.
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Cancer-Fighting Tomato Component Traced
The metabolic pathway associated with lycopene, the bioactive red pigment found in tomatoes, has been traced by researchers at the University of Illinois.
Circadian Clock Controls Insulin and Blood Sugar in Pancreas
Map of thousands of genes suggests new therapeutic targets for diabetes.
Cellular Stress Process Identified in Cardiovascular Disease
Combining the investigative tools of genetics, transcriptomics, epigenetics and metabolomics, a Duke Medicine research team has identified a new molecular pathway involved in heart attacks and death from heart disease.
Predicting Adverse Drug Reactions with Higher Confidence
A new integrated computational method helps predicting adverse drug reaction—which are often lethal—more reliably than with traditional computing methods.
A New Way to Starve Lung Cancer?
Metabolic alterations in lung cancer may open new avenues for treating the disease.
Evidence of How Incurable Cancer Develops
Researchers in the West Midlands have made a breakthrough in explaining how an incurable type of blood cancer develops from an often symptomless prior blood disorder.
Building a Better Liposome
Computational models suggest new design for nanoparticles used in targeted drug delivery.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos